Terapia hiperosmolar en hipertensión endocraneana

Referencias

1. Treggiari MM, Schutz N, Yanez ND, Romand J-A. Role of intracranial pressure values and patterns in predicting outcome of traumatic brain injury: a systematic review. Neurocrit Care 2007;6:104-12.
2. Palo J, Viitala S. Diagnosis and frequency of brain death. Lancet 1999;354:1909-10.
3. Baker A, Beed S, Fenwick J, et al. Number of deaths by neurological criteria, and organ and tissue donation rates at three critical care centres in Canada. Can J Anaesth 2006;53:722-6.
4. Langlois JA, Rutland-Brown W, Thomas KE. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002-2006. Atlanta: National Center for Injury Prevention and Control, 2006 (http://www.cdc.gov/traumaticbraininjury/pdf/blue_book.pdf).
5. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil 1999;14:602-15.
6. Monro A. Observations on the structure and function of the nervous system. Edinburgh: Creech and Johnson, 1835:5.
7. Kellie G. An account of the appearances observed in the dissection of two of three individuals presumed to have perished in the storm of the 3rd, and whose bodies were discovered in the vicinity of Leith on the morning of the 4th November 1821 with some reflections on the pathology of the brain. Trans Med Chir Sci Edinb 1824;1:84-169.
8. Weed LH, McKibbon PS. Pressure changes in the cerebrospinal fluid following intravenous injection of solutions of various concentrations. Am J Physiol 1919;48:512-30.
9. Muizelaar JP, Wei EP, Kontos HA, Becker DP. Mannitol causes compensatory cerebral vasoconstriction in response to blood viscosity changes. J Neurosurg 1983;59:822-8.
10. Videen TO, Zazulia AR, Manno EM, et al. Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology 2001;57:2120-2.
11. McDowell ME, Wolf AV, Steer A. Osmotic volumes of distribution: idiogenic changes in osmotic pressure associated with administration of hypertonic solutions. Am J Physiol 1955;180:545-58.
12. Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med 2000;342:1493-9.
13. Javid M, Settlage P. Effect of urea on cerebrospinal fluid pressure in human subjects: preliminary report. JAMA 1956;160:943-9.
14. Wise BL, Chater N. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinalfluid pressure. J Neurosurg 1962;19:1038-43.
15. Fisher B, Thomas D, Peterson B. Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neurosurg Anesthesiol 1992;4:4-10.
16. Koenig MA, Bryan M, Lewin JL III, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008;70:1023-9.
17. Francony G, Fauvage B, Falcon D, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008;36:795-800.
18. Vialet R, Albanèse J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003;31:1683-7.
19. Horn P, Münch E, Vajkoczy P, et al. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res 1999;21:758-64. 20. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer’s solution versus hypertonic saline. Crit Care Med 1998;26:1265-70.
21. Cooper DJ, Rosenfeld JV, Murray L, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med 2011;364:1493-502. [Erratum, N Engl J Med 2011;365:2040.]
22. CRASH Trial Collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004;364:1321-8.
23. James HE, Langfitt TW, Kumar VS, Ghostine SY. Treatment of intracranial hypertension: analysis of 105 consecutive continuous recordings of intracranial pressure. Acta Neurochir (Wien) 1977;36:189-200.
24. Better OS, Rubinstein I, Winaver JM, Knochel JP. Mannitol therapy revisited (1940-1997). Kidney Int 1997;52:886-94.
25. Paczynski RP. Osmotherapy: basic concepts and controversies. Crit Care Clin 1997;13:105-29.
26. Juul N, Morris GF, Marshall SB, Marshall LF. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. J Neurosurg 2000;92:1-6.
27. Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care 2004;1:219-33.
28. Bullock MR, Povlishock JT. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma 2007;24:Suppl 1:S14-S20. [Erratum, J Neurotrauma 2008;25:276-8.]
29. Kochanek PM, Carney N, Adelson PD, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents — second edition. Pediatr Crit Care Med 2012;13:Suppl 1:S1-S82. [Erratum, Pediatr Crit Care Med 2012;13:252.]